These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33167975)

  • 21. Complete genomic characterization in patients with cancer of unknown primary origin in routine diagnostics.
    Schipper LJ; Samsom KG; Snaebjornsson P; Battaglia T; Bosch LJW; Lalezari F; Priestley P; Shale C; van den Broek AJ; Jacobs N; Roepman P; van der Hoeven JJM; Steeghs N; Vollebergh MA; Marchetti S; Cuppen E; Meijer GA; Voest EE; Monkhorst K
    ESMO Open; 2022 Dec; 7(6):100611. PubMed ID: 36463731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples.
    de Schaetzen van Brienen L; Larmuseau M; Van der Eecken K; De Ryck F; Robbe P; Schuh A; Fostier J; Ost P; Marchal K
    BMC Med Genomics; 2020 Jul; 13(1):94. PubMed ID: 32631411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validity of whole genomes sequencing results in neoplasms in precision medicine.
    Echejoh G; Liu Y; Chung-Faye G; Charlton J; Moorhead J; Clark B; Davidson P; Sarker D; Ross P; Ooft ML
    J Clin Pathol; 2021 Nov; 74(11):718-723. PubMed ID: 33122190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
    Singer F; Irmisch A; Toussaint NC; Grob L; Singer J; Thurnherr T; Beerenwinkel N; Levesque MP; Dummer R; Quagliata L; Rothschild SI; Wicki A; Beisel C; Stekhoven DJ
    BMC Med Inform Decis Mak; 2018 Oct; 18(1):89. PubMed ID: 30373609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. From cytogenetics to cytogenomics: whole-genome sequencing as a first-line test comprehensively captures the diverse spectrum of disease-causing genetic variation underlying intellectual disability.
    Lindstrand A; Eisfeldt J; Pettersson M; Carvalho CMB; Kvarnung M; Grigelioniene G; Anderlid BM; Bjerin O; Gustavsson P; Hammarsjö A; Georgii-Hemming P; Iwarsson E; Johansson-Soller M; Lagerstedt-Robinson K; Lieden A; Magnusson M; Martin M; Malmgren H; Nordenskjöld M; Norling A; Sahlin E; Stranneheim H; Tham E; Wincent J; Ygberg S; Wedell A; Wirta V; Nordgren A; Lundin J; Nilsson D
    Genome Med; 2019 Nov; 11(1):68. PubMed ID: 31694722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing a dynamic simulation model to support the nationwide implementation of whole genome sequencing in lung cancer.
    van de Ven M; IJzerman M; Retèl V; van Harten W; Koffijberg H
    BMC Med Res Methodol; 2022 Mar; 22(1):83. PubMed ID: 35350994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study.
    Pankhurst LJ; Del Ojo Elias C; Votintseva AA; Walker TM; Cole K; Davies J; Fermont JM; Gascoyne-Binzi DM; Kohl TA; Kong C; Lemaitre N; Niemann S; Paul J; Rogers TR; Roycroft E; Smith EG; Supply P; Tang P; Wilcox MH; Wordsworth S; Wyllie D; Xu L; Crook DW;
    Lancet Respir Med; 2016 Jan; 4(1):49-58. PubMed ID: 26669893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation and Implementation of Clinical Laboratory Improvements Act-Compliant Whole-Genome Sequencing in the Public Health Microbiology Laboratory.
    Kozyreva VK; Truong CL; Greninger AL; Crandall J; Mukhopadhyay R; Chaturvedi V
    J Clin Microbiol; 2017 Aug; 55(8):2502-2520. PubMed ID: 28592550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new generation of cancer genome diagnostics for routine clinical use: overcoming the roadblocks to personalized cancer medicine.
    Heuckmann JM; Thomas RK
    Ann Oncol; 2015 Sep; 26(9):1830-1837. PubMed ID: 25899787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single whole genome sequencing analysis blazes the trail for precision medicine.
    Napoli GC; Chau CH; Figg WD
    Cancer Biol Ther; 2022 Dec; 23(1):134-135. PubMed ID: 35129071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-Wide Sequencing for Unexplained Developmental Disabilities or Multiple Congenital Anomalies: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2020; 20(11):1-178. PubMed ID: 32194879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting.
    Mazzonetto PC; Villela D; da Costa SS; Krepischi ACV; Milanezi F; Migliavacca MP; Pierry PM; Bonaldi A; Almeida LGD; De Souza CA; Kroll JE; Paula MG; Guarischi-Sousa R; Scapulatempo-Neto C; Rosenberg C
    Ann Hum Genet; 2024 Mar; 88(2):113-125. PubMed ID: 37807935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Challenges in the clinical implementation of precision medicine companion diagnostics.
    Keeling P; Clark J; Finucane S
    Expert Rev Mol Diagn; 2020 Jun; 20(6):593-599. PubMed ID: 32336167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-tuberculous drugs.
    Phelan JE; O'Sullivan DM; Machado D; Ramos J; Oppong YEA; Campino S; O'Grady J; McNerney R; Hibberd ML; Viveiros M; Huggett JF; Clark TG
    Genome Med; 2019 Jun; 11(1):41. PubMed ID: 31234910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
    Subhash VV; Huang L; Kamili A; Wong M; Chen D; Venn NC; Atkinson C; Mayoh C; Venkat P; Tyrrell V; Marshall GM; Cowley MJ; Ekert PG; Norris MD; Haber M; Henderson MJ; Sutton R; Fletcher JI; Trahair TN
    Br J Cancer; 2022 Feb; 126(3):482-491. PubMed ID: 34471258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implementation of whole genome sequencing for tuberculosis diagnostics in a low-middle income, high MDR-TB burden country.
    Vogel M; Utpatel C; Corbett C; Kohl TA; Iskakova A; Ahmedov S; Antonenka U; Dreyer V; Ibrahimova A; Kamarli C; Kosimova D; Mohr V; Sahalchyk E; Sydykova M; Umetalieva N; Kadyrov A; Kalmambetova G; Niemann S; Hoffmann H
    Sci Rep; 2021 Jul; 11(1):15333. PubMed ID: 34321545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants.
    Garcia M; Juhos S; Larsson M; Olason PI; Martin M; Eisfeldt J; DiLorenzo S; Sandgren J; Díaz De Ståhl T; Ewels P; Wirta V; Nistér M; Käller M; Nystedt B
    F1000Res; 2020; 9():63. PubMed ID: 32269765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.